Treatment of Psychosis and Agitation in Alzheimer's Disease

NCT02129348 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease
Psychosis
Agitation

Interventions

DRUG: Lithium
DRUG: Placebo

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]